Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SUBSTANCE-P ANTAGONIST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 159 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Caron, S; Massett, SS; Bogle, DE; Castaldi, MJ; Braish, TF
      An efficient and cost-effective synthesis of 2-phenyl-3-aminopyridine

      ORGANIC PROCESS RESEARCH & DEVELOPMENT
    2. Aitken, DJ; Ongeri, S; Vallee-Goyet, D; Gramain, JC; Husson, HP
      Synthesis, modelling and NK1 antagonist evaluation of a non-rigid cyclopropane-containing analogue of CP-99,994

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Gurrath, M
      Peptide-binding G protein-coupled receptors: New opportunities for drug design

      CURRENT MEDICINAL CHEMISTRY
    4. Raab, CE; Dean, DC; Melillo, DG
      Carbon-14 labeling of a trifluoromethoxy group: synthesis of a substance Pantagonist

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    5. Goldstein, DJ; Offen, WW; Klein, EG; Phebus, LA; Hipskind, P; Johnson, KW; Ryan, RE
      Lanepitant, an NK-1 antagonist, in migraine prevention

      CEPHALALGIA
    6. Hibino, S; Choshi, T
      Simple indole alkaloids and those with a nonrearranged monoterpenoid unit

      NATURAL PRODUCT REPORTS
    7. Cheeta, S; Tucci, S; Sandhu, J; Williams, AR; Rupniak, NMJ; File, SE
      Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils

      BRAIN RESEARCH
    8. Kumar, GK; Kou, YR; Overholt, JL; Prabhakar, NR
      Involvement of substance P in neutral endopeptidase modulation of carotid body sensory responses to hypoxia

      JOURNAL OF APPLIED PHYSIOLOGY
    9. Van Emelen, K; De Wit, T; Hoornaert, GJ; Compernolle, FA
      Diastereoselective intramolecular Ritter reaction: Generation of a cis-fused hexahydro-4aH-indeno[1,2-b]pyridine ring system with 4a,9b-diangular substituents

      ORGANIC LETTERS
    10. Berggreen, P; Grondahl, ML; Ersboll, AK; Maltbaek, JS; Thorboll, JE; Skadhauge, E; Hansen, MB
      Regional differences in neurogenic signal transduction pathway of cholera toxin-induced fluid, electrolyte and serotonin accumulation in the porcine jejunum

      PHARMACOLOGY & TOXICOLOGY
    11. Balasko, M; Szekely, M; Szelenyi, Z
      The effect of CP-96,345, a non-peptide substance-P antagonist, on thermoregulation and the development of endotoxin-fever in rats

      JOURNAL OF THERMAL BIOLOGY
    12. Campbell, EA; Gentry, C; Patel, S; Kidd, B; Cruwys, S; Fox, AJ; Urban, L
      Oral anti-hyperalgesic and anti-inflammatory activity of NK1 receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig

      PAIN
    13. Okamura, H; Shimizu, H; Nakamura, Y; Iwagawa, T; Nakatani, M
      Asymmetric synthesis of the key intermediate of an SP antagonist RPR107880using a base-catalyzed Diels-Alder reaction

      TETRAHEDRON LETTERS
    14. Pispisa, B; Stella, L; Venanzi, M; Palleschi, A
      A spectroscopic and molecular modeling study on novel pseudopeptides exhibiting biological activity

      JOURNAL OF PEPTIDE RESEARCH
    15. Liang, XQ; Wang, ZZ; Zhang, LS; Ni, DF
      Suppressing effect of substance P receptor antagonist on sound evoked potentials recorded from the guinea pig cochlea

      CHINESE MEDICAL JOURNAL
    16. Kingery, WS; Castellote, JM; Maze, M
      Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds

      PAIN
    17. Henry, JL; Yashpal, K; Pitcher, GM; Chabot, JG; Coderre, TJ
      Evidence for tonic activation of NK-1 receptors during the second phase ofthe formalin test in the rat

      JOURNAL OF NEUROSCIENCE
    18. Di Sebastiano, P; Grossi, L; Di Mola, FF; Angelucci, D; Friess, H; Marzio, L; Innocenti, P; Buchler, MW
      SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis

      DIGESTIVE DISEASES AND SCIENCES
    19. Li, YQ; Sugase, K; Ishiguro, M
      Synthesis of the cyclic heptapeptide Substance P antagonist, dihydro-WIN67689 and determination of the stereochemistry of the modified tyrosine moiety

      TETRAHEDRON LETTERS
    20. Okamura, H; Iwagawa, T; Nakatani, M
      Development of base catalyzed Diels-Alder reaction of 3-hydroxy-2-pyrone and application to synthesis of biologically active compounds

      JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN
    21. Natsugari, H; Ikeura, Y; Kamo, I; Ishimaru, T; Ishichi, Y; Fujishima, U; Tanaka, T; Kasahara, F; Kawada, M; Doi, T
      Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK1 receptor antagonists: Synthesis, antagonistic activity, and effects on bladder functions

      JOURNAL OF MEDICINAL CHEMISTRY
    22. Scott, JA; McCormack, DG
      Nonadrenergic noncholinergic vasodilation of guinea pig pulmonary arteriesis mediated by nitric oxide

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    23. Nyeki, O; Rill, A; Schon, I; Orosz, A; Schrett, J; Bartha, L; Nagy, J
      Synthesis of peptide and pseudopeptide amides inhibiting the proliferationof small cell and epithelial types of lung carcinoma cells

      JOURNAL OF PEPTIDE SCIENCE
    24. ELLIOTT JM; CASCIERI MA; CHICCHI G; DAVIES S; KELLEHER FJ; KURTZ M; LADDUWAHETTY T; LEWIS RT; MACLEOD AM; MERCHANT KJ; SADOWSKI S; STEVENSON GI
      SERINE DERIVED NK1 ANTAGONISTS 1 - THE EFFECT OF MODIFICATIONS TO THESERINE SUBSTITUENTS

      Bioorganic & medicinal chemistry letters
    25. YAMABE M; HOSOKAWA T; TAOKA T; MISAWA M
      A NEW PHARYNGITIS MODEL USING CAPSAICIN IN RATS

      General pharmacology
    26. EDVINSSON L; GULBENKIAN S; BARROSO CP; SA MCE; POLAK JM; MORTENSEN A; JORGENSEN L; JANSENOLESEN I
      INNERVATION OF THE HUMAN MIDDLE MENINGEAL ARTERY - IMMUNOHISTOCHEMISTRY, ULTRASTRUCTURE, AND ROLE OF ENDOTHELIUM FOR VASOMOTILITY

      Peptides (New York, N.Y. 1980)
    27. JONKMANDEVRIES JD; ROSING H; TALSMA H; HENRAR REC; KETTENESVANDENBOSCH JJ; BULT A; BEIJNEN JH
      PHARMACEUTICAL DEVELOPMENT OF A PARENTERAL LYOPHILIZED FORMULATION OFTHE INVESTIGATIONAL ANTITUMOR NEUROPEPTIDE ANTAGONIST [ARG(6), D-TRP(7,9), MEPHE(8)]-SUBSTANCE P (6-11)

      Investigational new drugs
    28. DUNSTAN AR; WEBER HP; RIHS G; WIDMER H; DZIADULEWICZ EK
      CONCISE AND REGIOSPECIFIC SYNTHESES OF TRI-SUBSTITUTED 1,2,4-TRIAZOLES

      Tetrahedron letters
    29. MAZELIN L; THEODOROU V; MORE J; EMONDSALT X; FIORAMONTI J; BUENO L
      COMPARATIVE EFFECTS OF NONPEPTIDE TACHYKININ RECEPTOR ANTAGONISTS ON EXPERIMENTAL GUT INFLAMMATION IN RATS AND GUINEA-PIGS

      Life sciences (1973)
    30. REINSHAGEN M; FLAMIG G; ERNST S; GEERLING I; WONG H; WALSH JH; EYSSELEIN VE; ADLER G
      CALCITONIN-GENE-RELATED PEPTIDE MEDIATES THE PROTECTIVE EFFECT OF SENSORY NERVES IN A MODEL OF COLONIC INJURY

      The Journal of pharmacology and experimental therapeutics
    31. IKEURA Y; ISHICHI Y; TANAKA T; FUJISHIMA A; MURABAYASHI M; KAWADA M; ISHIMARU T; KAMO I; DOI T; NATSUGARI H
      AXIALLY CHIRAL -DIMETHYL-5-PHENYL-1,7-NAPHTHYRIDINE-6-CARBOXAMIDE DERIVATIVES AS TACHYKININ NK1 RECEPTOR ANTAGONISTS - DETERMINATION OF THEABSOLUTE STEREOCHEMICAL REQUIREMENTS

      Journal of medicinal chemistry
    32. THORBOLL JE; BINDSLEV N; HANSEN MB; SCHMIDT P; SKADHAUGE E
      FUNCTIONAL-CHARACTERIZATION OF TACHYKININ RECEPTORS MEDIATING ION-TRANSPORT IN PORCINE JEJUNUM

      European journal of pharmacology
    33. BIENAYME H
      ENANTIOSELECTIVE DIELS-ALDER CYCLOADDITION BY PREORGANIZATION ON A CHIRAL LEWIS-ACID TEMPLATE

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    34. GIARDINA GAM; RAVEGLIA LF
      NEUROKININ-3 RECEPTOR ANTAGONISTS

      Expert opinion on therapeutic patents
    35. JACOBY E; BOUDON A; KUCHARCZYK N; MICHEL A; FAUCHERE JL
      A STRUCTURAL RATIONALE FOR THE DESIGN OF WATER-SOLUBLE PEPTIDE-DERIVED NEUROKININ-1 ANTAGONISTS

      Journal of receptor and signal transduction research
    36. REINSHAGEN M; EGGER B; PROCACCINO F; EYSSELEIN VE
      NEUROPEPTIDES IN INFLAMMATORY BOWEL-DISEASE - AN UPDATE

      Inflammatory bowel diseases
    37. KOHROGI H; YAMAGUCHI T; IWAGOE H; FUJII K; HAMAMOTO J; KAWANO O; ANDO M
      EVIDENCE THAT ALLERGEN-INDUCED CONTRACTION OF GUINEA-PIG BRONCHI IS MEDIATED IN PART BY THE RELEASE OF TACHYKININS

      International archives of allergy and immunology
    38. BOKS GJ; TOLLENAERE JP; KROON J
      POSSIBLE LIGAND-RECEPTOR INTERACTIONS FOR NK1 ANTAGONISTS AS OBSERVEDIN THEIR CRYSTAL-STRUCTURES

      Bioorganic & medicinal chemistry
    39. VEENSTRA SJ; HAUSER K; FELBER P
      STUDIES ON THE ACTIVE CONFORMATION OF THE NK1 ANTAGONIST GCP-49823 .2. FLUORO-OLEFIN ANALOGS OF TERTIARY AMIDE ROTAMERS

      Bioorganic & medicinal chemistry letters
    40. KASHEVEROV IE; UTKIN YN; TSETLIN VI
      ANTAGONISTS OF THE TACHYKININ RECEPTORS

      Bioorganiceskaa himia
    41. LASCHAT S; FOX T
      ENANTIOSELECTIVE APPROACH TOWARDS POTENTIAL SUBSTANCE-P ANTAGONISTS VIA HETERO-ENE REACTION OF PHENYLGLYCINE DERIVATIVES

      Synthesis
    42. KAGEYAMA M; FUJITA H; NAKATA K; SHIRASAWA E
      INVOLVEMENT OF BOTH L-TYPE AND N-TYPE VOLTAGE-DEPENDENT CA2-EVOKED AND VERATRIDINE-EVOKED TRANSMITTER RELEASE FROM NONADRENERGIC, NONCHOLINERGIC NERVES IN THE RABBIT IRIS SPHINCTER MUSCLE( CHANNELS IN KCL)

      Naunyn-Schmiedeberg's archives of pharmacology
    43. MATSUMOTO S
      THE CHANGES IN PULMONARY C-FIBER ACTIVITY AND LUNG-MECHANICS INDUCED BY VAGAL-STIMULATION IN RABBITS

      Life sciences
    44. MATSUMOTO S; TAKEDA M; SAIKI C; TAKAHASHI T; OJIMA K
      EFFECTS OF TACHYKININS ON RAPIDLY ADAPTING PULMONARY STRETCH RECEPTORS AND TOTAL LUNG RESISTANCE IN ANESTHETIZED, ARTIFICIALLY VENTILATED RABBITS

      The Journal of pharmacology and experimental therapeutics
    45. IYENGAR S; HIPSKIND PA; GEHLERT DR; SCHOBER D; LOBB KL; NIXON JA; HELTON DR; KALLMAN MJ; BOUCHER S; COUTURE R; LI DL; SIMMONS RMA
      LY303870, A CENTRALLY ACTIVE NEUROKININ-1 ANTAGONIST WITH A LONG-DURATION OF ACTION

      The Journal of pharmacology and experimental therapeutics
    46. KRAMER JH; PHILLIPS TM; WEGLICKI WB
      MAGNESIUM-DEFICIENCY-ENHANCED POSTISCHEMIC MYOCARDIAL INJURY IS REDUCED BY SUBSTANCE-P RECEPTOR BLOCKADE

      Journal of Molecular and Cellular Cardiology
    47. GIARDINA GAM; SARAU HM; FARINA C; MEDHURST AD; GRUGNI M; RAVEGLIA LF; SCHMIDT DB; RIGOLIO R; LUTTMANN M; VECCHIETTI V; HAY DWP
      DISCOVERY OF A NOVEL CLASS OF SELECTIVE NONPEPTIDE ANTAGONISTS FOR THE HUMAN NEUROKININ-3 RECEPTOR .1. IDENTIFICATION OF THE 4-QUINOLINECARBOXAMIDE FRAMEWORK

      Journal of medicinal chemistry
    48. TURCATTI G; ZOFFMANN S; LOWE JA; DROZDA SE; CHASSAING G; SCHWARTZ TW; CHOLLET A
      CHARACTERIZATION OF NONPEPTIDE ANTAGONIST AND PEPTIDE AGONIST BINDING-SITES OF THE NK1 RECEPTOR WITH FLUORESCENT LIGANDS

      The Journal of biological chemistry
    49. BUENO L; FIORAMONTI J; DELVAUX M; FREXINOS J
      MEDIATORS AND PHARMACOLOGY OF VISCERAL SENSITIVITY - FROM BASIC TO CLINICAL INVESTIGATIONS

      Gastroenterology
    50. IKEURA Y; TANAKA T; KIYOTA Y; MORIMOTO S; OGINO M; ISHIMARU T; KAMO I; DOI T; NATSUGARI H
      POTENT NK1 RECEPTOR ANTAGONISTS - SYNTHESIS AND ANTAGONISTIC ACTIVITYOF VARIOUS HETEROCYCLES WITH AN [3,5-BIS(TRIFLUOROMETHYL)BENZYL]-N-METHYLCARBAMOYL SUBSTITUENT

      Chemical and Pharmaceutical Bulletin
    51. YUAN YD; COUTURE R
      RENAL EFFECTS OF INTRATHECALLY INJECTED TACHYKININS IN THE CONSCIOUS SALINE-LOADED RAT - RECEPTOR AND MECHANISM OF ACTION

      British Journal of Pharmacology
    52. SLUKA KA; MILTON MA; WILLIS WD; WESTLUND KN
      DIFFERENTIAL ROLES OF NEUROKININ-1 AND NEUROKININ-2 RECEPTORS IN THE DEVELOPMENT AND MAINTENANCE OF HEAT HYPERALGESIA INDUCED BY ACUTE-INFLAMMATION

      British Journal of Pharmacology
    53. YUAN YD; COUTURE R
      RENAL EFFECTS OF INTRACEREBROVENTRICULARLY INJECTED TACHYKININS IN THE CONSCIOUS SALINE-LOADED RAT - RECEPTOR CHARACTERIZATION

      British Journal of Pharmacology
    54. DENISE DD; SHANDS EFB
      SYSTEMATIC SEARCH STRATEGIES IN CONFORMATIONAL-ANALYSIS

      Drug discovery today
    55. KHAWAJA AM; ROGERS DF
      TACHYKININS - RECEPTOR TO EFFECTOR

      International journal of biochemistry & cell biology
    56. KUROIWA C; UMENO E; NOGAMI H; KANO S; HIROSE T; NISHIMA S
      ROLE OF TACHYKININS IN BRONCHOCONSTRICTION INDUCED BY INTRAVENOUS ADMINISTRATION OF BRADYKININ IN GUINEA-PIGS

      The European respiratory journal
    57. MALINOVSKY JM; PINAUD M
      THE NEUROTOXICITY OF INTRATHECALLY ADMINI STERED AGENTS

      Annales francaises d'anesthesie et de reanimation
    58. PINCELLI C; FANTINI F; GIANNETTI A
      NEUROPEPTIDES, NERVE GROWTH-FACTOR AND THE SKIN

      Pathologie et biologie
    59. YUAN LQ; BURCHER E; NAIL B
      TACHYKININ RECEPTORS AND NONCHOLINERGIC BRONCHOCONSTRICTION IN THE ANESTHETIZED GUINEA-PIG

      Clinical and experimental pharmacology and physiology
    60. FONG TM; YU H; HUANG RRC; CASCIERI MA; SWAIN CJ
      RELATIVE CONTRIBUTION OF POLAR INTERACTIONS AND CONFORMATIONAL COMPATIBILITY TO THE BINDING OF NEUROKININ-1 RECEPTOR ANTAGONISTS

      Molecular pharmacology
    61. SAGAN S; CHASSAING G; PRADIER L; LAVIELLE S
      TACHYKININ PEPTIDES AFFECT DIFFERENTLY THE 2ND-MESSENGER PATHWAYS AFTER BINDING TO CHO-EXPRESSED HUMAN NK-1 RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    62. HIPSKIND PA; HOWBERT JJ; BRUNS RF; CHO SSY; CROWELL TA; FOREMAN MM; GEHLERT DR; IYENGAR S; JOHNSON KW; KRUSHINSKI JH; LI DL; LOBB KL; MASON NR; MUEHL BS; NIXON JA; PHEBUS LA; REGOLI D; SIMMONS RM; THRELKELD PG; WATERS DC; GITTER BD
      3-ARYL-1,2-DIACETAMIDOPROPANE DERIVATIVES AS NOVEL AND POTENT NK-1 RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    63. LADDUWAHETTY T; BAKER R; CASCIERI MA; CHAMBERS MS; HAWORTH K; KEOWN LE; MACINTYRE DE; METZGER JM; OWEN S; RYCROFT W; SADOWSKI S; SEWARD EM; SHEPHEARD SL; SWAIN CJ; TATTERSALL FD; WATT AP; WILLIAMSON DW; HARGREAVES RJ
      N-HETEROARYL-2-PHENYL-3-(BENZYLOXY)PIPERIDINES - A NOVEL CLASS OF POTENT ORALLY-ACTIVE HUMAN NK1 ANTAGONISTS

      Journal of medicinal chemistry
    64. HIRSCHMANN R; YAO WQ; CASCIERI MA; STRADER CD; MAECHLER L; CICHYKNIGHT MA; HYNES J; VANRIJN RD; SPRENGELER PA; SMITH AB
      SYNTHESIS OF POTENT CYCLIC HEXAPEPTIDE NK-1 ANTAGONISTS - USE OF A MINILIBRARY IN TRANSFORMING A PEPTIDAL SOMATOSTATIN RECEPTOR-LIGAND INTOAN NK-1 RECEPTOR-LIGAND VIA A POLYVALENT PEPTIDOMIMETIC

      Journal of medicinal chemistry
    65. BONNET J; KUCHARCZYK N; ROBINEAU P; LONCHAMPT M; DACQUET C; REGOLI D; FAUCHERE JL; CANET E
      A WATER-SOLUBLE, STABLE DIPEPTIDE NK1 RECEPTOR-SELECTIVE NEUROKININ RECEPTOR ANTAGONIST WITH POTENT IN-VIVO PHARMACOLOGICAL EFFECTS - S18523

      European journal of pharmacology
    66. HAN YC; SHAIKH MB; SIEGEL A
      MEDIAL AMYGDALOID SUPPRESSION OF PREDATORY ATTACK BEHAVIOR IN THE CAT.1. ROLE OF A SUBSTANCE-P PATHWAY FROM THE MEDIAL AMYGDALA TO THE MEDIAL HYPOTHALAMUS

      Brain research
    67. VERLEDEN GM
      NEURAL MECHANISMS AND AXON REFLEXES IN ASTHMA - WHERE ARE WE

      Biochemical pharmacology
    68. KRISTENSEN JD; KARLSTEN R; GORDH T
      SPINAL-CORD BLOOD-FLOW AFTER INTRATHECAL INJECTION OF ROPIVACAINE - ASCREENING FOR NEUROTOXIC EFFECTS

      Anesthesia and analgesia
    69. FANTINI F; MAGNONI C; PINCELLI C; GIANNETTI A
      NEUROGENIC INFLAMMATION AND THE SKIN NEURAL MODULATION OF CUTANEOUS INFLAMMATORY REACTIONS

      EJD. European journal of dermatology
    70. LIVNI E; BABICH JW; DESAI MC; GODEK DM; WILKINSON RA; RUBIN RH; FISCHMAN AJ
      SYNTHESIS OF A C-11 LABELED NK1 RECEPTOR-LIGAND FOR PET STUDIES

      Nuclear medicine and biology
    71. ARMOUR DR; WATSON SP; PEGG NA; HERON NM; MIDDLEMISS D; CHAN C; CHOLERTON TJ; HUBBARD T; VINADER MV; DAVIES HG; COCKER JD; BAYS DE; WARD P
      SPIRO-PIPERIDINE NONPEPTIDE NEUROKININ-1 RECEPTOR ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    72. GITTER BD; WATERS DC; THRELKELD PG; LOVELACE AM; MATSUMOTO K; BRUNS RF
      CYCLOSPORINE-A IS A SUBSTANCE-P (TACHYKININ NK1) RECEPTOR ANTAGONIST

      European journal of pharmacology. Molecular pharmacology section
    73. RADHAKRISHNAN V; HENRY JL
      ANTAGONISM OF NOCICEPTIVE RESPONSES OF CAT SPINAL DORSAL HORN NEURONSIN-VIVO BY THE NK-1 RECEPTOR ANTAGONISTS CP-96,345 AND CP-99,994, BUTNOT BY CP-96,344

      Neuroscience
    74. BESIDSKY Y; LUTHMAN K; CLAESSON A; FOWLER CJ; CSOREGH I; HACKSELL U
      SYNTHESIS OF PERHYDRO-1,4-ETHANO-1,5-NAPHTHYRIDINE AND PERHYDRO-4,7-ETHANOPYRROLO[3,2-B]PYRIDINE DERIVATIVES - POTENTIAL NK1-RECEPTOR ANTAGONISTS - X-RAY MOLECULAR-STRUCTURES OF -OXO-8-PHENYLPERHYDRO-1,4-ETHANO-1,5-NAPHTHYRIDINE AND -7,8-DIPHENYLPERHYDRO-1,4-ETHANO-1,5-NAPHTHYRIDINE

      Journal of the Chemical Society. Perkin transactions. I
    75. DANIEL EE; PARRISH MB; WATSON EG; FOXTHRELKELD JET; REGOLI D; RAINSFORD KD
      THE TACHYKININ RECEPTORS INDUCING CONTRACTILE RESPONSES OF CANINE ILEUM CIRCULAR MUSCLE

      American journal of physiology: Gastrointestinal and liver physiology
    76. GAO GC; WEI ET
      INHIBITION OF SUBSTANCE-P-INDUCED VASCULAR LEAKAGE IN RAT BY N-ACETYL-NEUROTENSIN-(8-13)

      Regulatory peptides
    77. PRABHAKAR NR; GOUDA E; KUMAR GK; KOU YR
      ANALYSIS OF CAROTID CHEMORECEPTOR RESPONSES TO SUBSTANCE-P ANALOG IN ANESTHETIZED CATS

      Journal of the autonomic nervous system
    78. FRIELING T; STROHMEYER G
      NEUROIMMUNE INTERACTION IN THE GASTROINTE STINAL-TRACT

      Zeitschrift fur Gastroenterologie
    79. MALLERON JL; PEYRONEL JF; DESMAZEAU P; MHOUMADI C; PLANIOL C
      SYNTHESIS OF PERHYDROCYCLOPENTA[C]PYRROLES BY A TANDEM REARRANGEMENT AUTOXIDATION REACTION

      Tetrahedron letters
    80. MAGGI CA; GIACHETTI A; DEY RD; SAID SI
      NEUROPEPTIDES AS REGULATORS OF AIRWAY FUNCTION - VASOACTIVE-INTESTINAL-PEPTIDE AND THE TACHYKININS

      Physiological reviews
    81. AMANN R; SCHULIGOI R; HOLZER P; DONNERER J
      THE NONPEPTIDE NK1 RECEPTOR ANTAGONIST SR140333 PRODUCES LONG-LASTINGINHIBITION OF NEUROGENIC INFLAMMATION, BUT DOES NOT INFLUENCE ACUTE CHEMONOCICEPTION OR THERMONOCICEPTION IN RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    82. STEVENSON GI; MACLEOD AM; HUSCROFT I; CASCIERI MA; SADOWSKI S; BAKER R
      4,4-DISUBSTITUTED PIPERIDINES - A NEW CLASS OF NK1 ANTAGONIST

      Journal of medicinal chemistry
    83. LEWIS RT; MACLEOD AM; MERCHANT KJ; KELLEHER F; SANDERSON I; HERBERT RH; CASCIERI MA; SADOWSKI S; BALL RG; HOOGSTEEN K
      TRYPTOPHAN-DERIVED NK1 ANTAGONISTS - CONFORMATIONALLY CONSTRAINED HETEROCYCLIC BIOISOSTERES OF THE ESTER LINKAGE

      Journal of medicinal chemistry
    84. WARD P; ARMOUR DR; BAYS DE; EVANS B; GIBLIN GMP; HERON N; HUBBARD T; LIANG K; MIDDLEMISS D; MORDAUNT J; NAYLOR A; PEGG NA; VINADER MV; WATSON SP; BOUNTRA C; EVANS DC
      DISCOVERY OF AN ORALLY BIOAVAILABLE NK1 RECEPTOR ANTAGONIST, -TETRAZOL-1-YLBENZYL)(2-PHENYLPIPERIDIN-3-YL)AMINE (GR203040), WITH POTENT ANTIEMETIC ACTIVITY

      Journal of medicinal chemistry
    85. SWAIN CJ; SEWARD EM; CASCIERI MA; FONG TM; HERBERT R; MACINTYRE DE; MERCHANT KJ; OWEN SN; OWENS AP; SABIN V; TEALL M; VANNIEL MB; WILLIAMS BJ; SADOWSKI S; STRADER C; BALL RG; BAKER R
      IDENTIFICATION OF A SERIES OF 3-(BENZYLOXY)-1-AZABICYCLO[2.2.2]OCTANEHUMAN NK1 ANTAGONISTS

      Journal of medicinal chemistry
    86. HAWCOCK AB; BERESFORD IJM; MARSHALL FH; HAGAN RM
      TEMPERATURE AND AGONIST DEPENDENCY OF TACHYKININ NK1 RECEPTOR ANTAGONIST POTENCIES IN RAT ISOLATED SUPERIOR CERVICAL-GANGLION

      European journal of pharmacology
    87. BETOIN F; ADVENIER C; FARDIN V; WILCOX G; LAVARENNE J; ESCHALIER A
      IN-VITRO AND IN-VIVO EVIDENCE FOR A TACHYKININ NK1 RECEPTOR ANTAGONIST EFFECT OF VAPREOTIDE, AN ANALGESIC CYCLIC ANALOG OF SOMATOSTATIN

      European journal of pharmacology
    88. RAYCHAUDHURI SP; REIN G; FARBER EM
      NEUROPATHOGENESIS AND NEUROPHARMACOLOGY OF PSORIASIS

      International journal of dermatology
    89. BEATTIE DT; CONNOR HE; HAGAN RM
      RECENT DEVELOPMENTS IN TACHYKININ NK1 RECEPTOR ANTAGONISTS - PROSPECTS FOR THE TREATMENT OF MIGRAINE HEADACHE

      Canadian journal of physiology and pharmacology
    90. RUPNIAK NMJ; WEBB JK; WILLIAMS AR; CARLSON E; BOYCE S; HILL RG
      ANTINOCICEPTIVE ACTIVITY OF THE TACHYKININ NK1 RECEPTOR ANTAGONIST, CP-99,994, IN CONSCIOUS GERBILS

      British Journal of Pharmacology
    91. HOLZERPETSCHE U; RORDORFNIKOLIC T
      CENTRAL VERSUS PERIPHERAL SITE OF ACTION OF THE TACHYKININ NK1-ANTAGONIST RP-67580 IN INHIBITING CHEMONOCICEPTION

      British Journal of Pharmacology
    92. CALIENDO G; CALIGNANO A; GRIECO P; MANCUSO F; PERISSUTTI E; SANTINI A; SANTAGADA V
      SYNTHESIS AND BIOLOGICAL-ACTIVITY OF TRIPEPTIDE FR113680 ANALOGS CONTAINING UNCONVENTIONAL AMINO-ACIDS

      Biopolymers
    93. SISTO A; BONELLI F; CENTINI F; FINCHAM CI; POTIER E; MONTEAGUDO E; LOMBARDI P; ARCAMONE F; GOSO C; MANZINI S; GIOLITTI A; MAGGI CA; VENANZI M; PISPISA B
      SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL NK-1 TACHYKININ RECEPTORANTAGONISTS - THE USE OF CYCLOALKYL AMINO-ACIDS AS A TEMPLATE

      Biopolymers
    94. PATACCHINI R; MAGGI CA
      TACHYKININ RECEPTORS AND RECEPTOR SUBTYPES

      Archives internationales de pharmacodynamie et de therapie
    95. GERMONPRE PR; JOOS GF; PAUWELS RA
      CHARACTERIZATION OF THE NEUROGENIC PLASMA EXTRAVASATION IN THE AIRWAYS

      Archives internationales de pharmacodynamie et de therapie
    96. ACHARD D; TRUCHON A; PEYRONEL JF
      PERHYDROTHIOPYRANOPYRROLES DERIVATIVES - A NOVEL SERIES OF POTENT ANDSELECTIVE NONPEPTIDE NK1 ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    97. TABART M; PEYRONEL JF
      SYNTHESIS OF RPR-100893, PROTOTYPE OF A NEW SERIES OF POTENT AND SELECTIVE NON PEPTIDE NK1 ANTAGONISTS - THE TRIARYLPERHYDROISOINDOLOLS

      Bioorganic & medicinal chemistry letters
    98. HARRISON T; WILLIAMS BJ; SWAIN CJ; BALL RG
      PIPERIDINE-ETHER BASED HNK(1) ANTAGONISTS .1. DETERMINATION OF THE RELATIVE AND ABSOLUTE STEREOCHEMICAL REQUIREMENTS

      Bioorganic & medicinal chemistry letters
    99. WILLIAMS BJ; TEALL M; MCKENNA J; HARRISON T; SWAIN CJ; CASCIERI MA; SADOWSKI S; STRADER C; BAKER R
      ACYCLIC NK-1 ANTAGONISTS - 2-BENZHYDRYL-2-AMINOETHYL ETHERS

      Bioorganic & medicinal chemistry letters
    100. WOOHEAD CJ
      NEUROPEPTIDES IN NASAL-MUCOSA

      Clinical otolaryngology and allied sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 11:14:31